Hepatocellular carcinoma and hepatitis B e antigen.
Hepatitis B e antigen serum persistence in an individual chronically infected with the Hepatitis B virus may be associated with a greatly increased risk of developing cirrhosis and hepatocellular carcinoma. This article presents an overview of the Hepatitis B e antigen and discusses the findings of a recent study evaluating its associated risk of hepatocellular carcinoma. A gross photographic image of hepatocellular carcinoma is provided.
Kane
Loren S
LS
Transamerica Reinsurance, 401 North Tryon Street, Suite 700, Charlotte, NC 28202, USA.
D006528:Carcinoma, Hepatocellular / Q000209:etiology / Q000473:pathology*; D006505:Hepatitis / Q000097:blood / Q000150:complications; D006509:Hepatitis B / Q000097:blood / Q000150:complications; D006512:Hepatitis B Core Antigens / Q000097:blood; D006513:Hepatitis B e Antigens / Q000097:blood*; D006515:Hepatitis B virus / Q000472:pathogenicity; D006801:Humans
D006512:Hepatitis B Core Antigens; D006513:Hepatitis B e Antigens